Newman Dignan & Sheerar Inc’s Adaptimmune Therapeutics ADAP Stock Holding History

Newman Dignan & Sheerar Inc’s Portfolio ADAP Stock Details ADAP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell
2025 Q2	$6.7K	Hold
2025 Q1	$5.51K	Hold
2024 Q4	$15.1K	Hold
2024 Q3	$20.6K	Buy
2024 Q1	–	Sell
2023 Q4	$18.3K	Buy
2023 Q3	–	Sell
2023 Q2	$17.9K	Buy